Welcome to our dedicated page for PROCTER & GAMBLE Co SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PROCTER & GAMBLE Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PROCTER & GAMBLE Co's regulatory disclosures and financial reporting.
The Procter & Gamble Company declared a quarterly dividend of $1.0885 per share on its Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after August 17, 2026.
Common Stock shareowners of record at the close of business on July 24, 2026 and ESOP Convertible Class A Preferred shareowners of record at the start of business on July 24, 2026 will be eligible. P&G reports it has paid dividends for 136 consecutive years and increased its dividend for 70 consecutive years, underscoring its focus on returning cash to shareowners.
PROCTER & GAMBLE Co executive Juliana Monteiro Santos de Azevedo, CEO – Grooming, reports her beneficial ownership of company equity. She holds 19,361.8513 shares of Common Stock directly and 331.2100 shares indirectly through an International Stock Ownership Plan & Pension Plan. She also holds multiple awards of Restricted Stock Units that can deliver P&G common stock or cash, and several stock options (rights to buy) Common Stock, including options over 17,440 shares at an exercise price of $156.83 expiring in 2035 and 36,482 shares at $153.18 expiring in 2035. Footnotes explain that certain RSUs are retirement awards and dividend equivalents that represent contingent rights to receive P&G common stock or cash based on the company’s retirement program formulas.
PROCTER & GAMBLE Co executive Juliana Monteiro Santos de Azevedo, CEO – Grooming, reported her initial beneficial ownership on a Form 3. She directly holds 19,361.8513 shares of common stock and indirectly holds 331.2100 shares through an International Stock Ownership Plan & Pension Plan. She also holds multiple grants of Restricted Stock Units that can settle in common stock or cash and several stock options to buy common shares at exercise prices between $128.5100 and $174.0800 with expirations from 2032-10-01 to 2035-10-01.
PROCTER & GAMBLE Co director Robert Jones Portman received 51 shares of common stock as a stock award. The award was reported at a price of $0.00 per share and represents Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Footnotes state the total reported amount includes dividend equivalents granted in the form of additional Restricted Stock Units. After this compensation-related acquisition, Portman’s directly held position increased to about 5,155.4641 shares, reflecting a routine equity grant rather than an open-market purchase.
McEvoy Ashley reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Ashley McEvoy received an equity award of 202 shares of Common Stock-equivalent Restricted Stock Units. The award was granted at no cash cost under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents paid in additional Restricted Stock Units. Following this grant, McEvoy directly holds a total of 5,986.2484 shares of Procter & Gamble common stock, reflecting a routine compensation-related increase in equity ownership rather than an open-market purchase.
PROCTER & GAMBLE Co director receives equity award through a grant of 253 shares of common stock on June 9, 2026, reported as a grant, award, or other acquisition at a stated price of $0.00 per share. The award represents Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents in the form of additional Restricted Stock Units. Following this compensation-related grant, Christine M. McCarthy directly holds a total of 17,512.6591 shares of Procter & Gamble common stock.
PROCTER & GAMBLE Co director Christopher J. Kempczinski reported an equity award on a Form 4. On June 9, 2026, he acquired 258 Restricted Stock Units at $0.00 per unit under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents, bringing his reported holdings to 11,595.5466 shares/units.
JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Joseph Jimenez reported receiving an award of 320 shares of Common Stock in the form of Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award was granted at no cash price as part of his equity compensation.
After this grant, Jimenez directly holds a total of 37,016.0703 shares of Common Stock, including prior awards and dividend equivalents credited in Restricted Stock Units.
ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Craig Arnold received an award of 202 shares of common stock in the form of Restricted Stock Units on 2026-06-09. The grant was made at $0.00 per share as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in additional RSUs.
After this compensation award, Arnold directly holds a total of 2,807.8441 shares. This is a routine equity grant rather than an open-market purchase or sale, and there are no remaining derivative positions disclosed in this filing.
PROCTER & GAMBLE Co executive Hesham Abd El Hak filed an initial Form 3 reporting his equity interests in the company. As CEO of Baby and Feminine Care, he reports direct ownership of 7,964.4034 shares of common stock and additional indirect holdings through retirement-related plans.
He also holds various stock options on P&G common stock, including grants covering 41,388 shares at an exercise price of $153.18 per share expiring in 2035 and 35,384 shares at $173.04 per share expiring in 2034. The filing lists multiple restricted stock unit and preferred stock-based retirement awards that are designed to settle in P&G common stock or cash under company benefit formulas.